Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oncogene
100%
Human Glioblastoma
100%
Cell-cycle Kinases
100%
Glioblastoma multiforme
55%
Confidence Interval
22%
Phosphorylation
22%
Knockdown
22%
Short Hairpin RNA (shRNA)
22%
Cyclin-dependent Kinase 2 (CDK2)
22%
U-87
22%
Patient Samples
22%
Statistical Test
11%
Chemotherapy
11%
Cell Growth
11%
Cell Proliferation
11%
Dose Effect
11%
Protein Kinase
11%
Quantitative PCR
11%
Tumorigenicity
11%
Overexpression
11%
Glioblastoma Cells
11%
Radiotherapy
11%
Glioma Cells
11%
U87MG
11%
Oncogenesis
11%
Tumor Cells
11%
Expression Level
11%
Cell Cycle Distribution
11%
Polymerase Chain Reaction Assay
11%
Tumorigenesis
11%
U87 Cells
11%
Small Interfering RNA (siRNA)
11%
Tumor Volume
11%
New Therapies
11%
Inhibiting Effect
11%
Glioma Cell Lines
11%
Glioma
11%
Cell Injection
11%
Novel Protein
11%
Nude Mouse Xenograft Model
11%
Glioblastoma multiforme Cells
11%
Normal Brain
11%
Median Survival
11%
CDK7
11%
Glioma Patients
11%
Human Glioma
11%
S Phase Cell Cycle Arrest
11%
Growth Hindering
11%
Combined Modality Therapy
11%
Normal Brain Tissues
11%
Neuroscience
Kinase
100%
Cell Cycle
100%
Oncogene
100%
Glioblastoma Multiforme
60%
In Vivo
20%
Cyclin Dependent Kinase 2
20%
Carcinogenesis
20%
Cell Line
10%
Small Hairpin RNA
10%
Protein Kinases
10%
Protein Kinase A
10%
Cell Proliferation
10%
Cyclin Dependent Kinase 7
10%
Small Interfering RNA
10%
Cell Growth
10%
Cell Cycle Checkpoint
10%
Messenger RNA
10%
Reverse Transcription Polymerase Chain Reaction
10%
Radiation Therapy
10%